PM
BEAT

Prosight Management’s BioTelemetry, Inc. BEAT Stock Holding History

Prosight Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,000
Closed -$274K – 62
2020
Q3 		$274K Sell
6,000
-18,733
-76% -$783K 0.13% 46
2020
Q2 		$1.12M Buy
+24,733
New +$1.11M 0.48% 44

Other funds holding BEAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Prosight Management's BEAT Position: Q4 2020 in Review

Prosight Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 6,000 shares — an estimated $274K sold.

Prosight Management first reported a position in BEAT in Q2 2020 and held it in 2 quarters. The position peaked at $1.12M in Q2 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Prosight Management reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Prosight Management sold 6,000 BioTelemetry, Inc. shares in Q4 2020, an estimated $274K.
  • Prosight Management first reported a position in BioTelemetry, Inc. in Q2 2020 and held it in 2 quarters.
  • Prosight Management's BioTelemetry, Inc. position peaked at $1.12M in Q2 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Prosight Management's 13F filing for Q4 2020, filed 12 Feb 2021.